Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Taysha Gene Therapies

Biotech & Life Sciences · Dallas, United States · Founded 2020 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.55B
Market cap · Apr/2026
Revenue
$9.8M
Latest reported FY

Investors

20 investors on Taysha Gene Therapies's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage
Nolan Capital
PBM Capital Group
Series B+ 18 investors entered at this stage
Franklin Templeton Investments
Octagon Capital Partners
Acuta Capital Partners
Kynam Capital Management
Casdin Capital
GordonMD Global Investment
TCGX
ArrowMark Partners
BlackRock
Perceptive Advisors
Invus
Sands Capital Management
B Capital
Venrock Healthcare Capital Partners
Venrock
RA Capital Management
RTW Investments
Fidelity Investments

Global footprint

Where Taysha Gene Therapies has talent and traffic

Web traffic by country
14K monthly visits
across markets
🇮🇳 India52.9%
🇺🇸 United States47.1%
🇨🇦 Canada2.9%
Top 3 markets shown

See Taysha Gene Therapies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo